Showing results (141-150 of 879) with videos related to
Sort By:
Pageof 88
The Journal of Antimicrobial Chemotherapy|September 18, 2009
Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infectionKaren E Bowker, Alan R Noel, Alasdair P MacGowanAntimicrobial Agents and Chemotherapy|June 4, 2008
Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic modelKaren E Bowker, Alan R Noel, Alasdair P MacgowanBritish Journal of Anaesthesia|November 1, 1979
Cardiorespiratory effects of the sitting position in neurosurgeryD G Dalrymple, S W MacGowan, G F MacLeodInternational Journal of Antimicrobial Agents|April 13, 2007
Development, evaluation and application of an isocratic high-performance liquid chromatography (HPLC) assay for the simultaneous determination of aciclovir and its metabolite 9-carboxymethoxymethylguanine in human serum and cerebrospinal fluidJ M Darville, A M Lovering, A P MacGowanBMC Medical Research Methodology|October 1, 2021
Analytical challenges in estimating the effect of exposures that are bounded by follow-up time: experiences from the Blood Stream Infection-Focus on Outcomes studyRebecca Evans, Katie Pike, Alasdair MacGowan, et al.Heart (British Cardiac Society)|November 14, 1998
Aorto-atrial fistula without aneurysm formation in Behçet's diseaseA Melua, N Campbell, D McCluskey, et al.BMJ Case Reports|May 25, 2017
Giant cell myocarditis presenting with acute heart failureIoannis Kasouridis, Joaquim Majo, Guy MacGowan, et al.Antimicrobial Agents and Chemotherapy|September 29, 2005
Pharmacodynamics of moxifloxacin against anaerobes studied in an in vitro pharmacokinetic modelAlan R Noel, Karen E Bowker, Alasdair P MacgowanThe American Journal of Cardiology|May 1, 1997
Exercise-related ventilatory abnormalities and survival in congestive heart failureG A MacGowan, K Janosko, A Cecchetti, et al.Antimicrobial Agents and Chemotherapy|January 30, 2008
Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infectionAlasdair P MacGowan, Karen E Bowker, Alan R NoelPageof 88